Page 38 - IJSA, Vol. 4, No 2, 2021

International Journal of Science Annals, Vol. 5, No. 1-2, 2022
рrint ISSN: 2617-2682; online ISSN: 2707-3637; DOI:10.26697/ijsa

World Health Organization classification of Pathology & Oncology Research, 25(3), 1253-
myeloid neoplasms and acute leukemia. Blood, 1258. https://doi.org/10.1007/s12253-018-0484-7
127(20), 2391-2405. Khoury, J. D., Solary, E., Abla, O., Akkari, Y.,
https://doi.org/10.1182/blood-2016-03-643544 Alaggio, R., Apperley, J. F., Bejar, R., Berti, E.,
Asif, M., Hussain, A., & Rasool, M. (2016). A rare case Busque, L., Chan, J. K. C., Chen, W., Chen, X.,
of a three way complex variant positive Chng, W.-J., Choi, J. K., Colmenero, I.,
Philadelphia translocation involving chromosome Coupland, S. E., Cross, N. C. P., De Jong, D.,
(9; 11; 22 (q34; p15; q11) in chronic myeloid Elghetany, M. T. … Hochhaus, A. (2022). The
leukemia: A case report. Oncology Letters, 12(3), 5th edition of the World Health Organization
1986-1988. https://doi.org/10.3892/ol.2016.4821 classification of haematolymphoid tumours:
Assi, R., & Short, N. (2020). Blast crisis of chronic Myeloid and histiocytic/dendritic neoplasms.
myeloid leukemia (CML). In Nates, J., & Leukemia, 36, 1703-1719.
Price, K. (Eds.), Oncologic Critical Care https://doi.org/10.1038/s41375-022-01613-1
(pp. 1135-1145). Springer, Cham. Narang, V., Sachdeva, M. U. S., Bose, P., Varma, N.,
https://doi.org/10.1007/978-3-319-74588-6_93 Malhotra, P. & Varma, S. (2016).
Barge, L., Cleary, R., Morris, K., & Simleit, E. (2022). Immunophenotyping in chronic myeloid
Incidence and immunophenotype of abnormal leukemia blast crisis: Looking beyond
lymphoblast populations at diagnosis of chronic morphology. Journal of Postgraduate Medicine,
myeloid leukaemia in chronic phase. Journal of Education and Research, 50(4), 181-184.
Hematopathology, 15, 51–56. https://doi.org/10.5005/jp-journals-10028-1215
https://doi.org/10.1007/s12308-022-00487-7 Pandey, M. K., & Pal, S. (2021). Evaluation of chronic
Bonifacio, M., Stagno, F., Scaffidi, L., Krampera, M., & myelogenous leukemia (CML) as the chronic
Di Raimondo, F. (2019). Management of chronic phase of disease using machine learning
myeloid leukemia in advanced phase. Frontiers in techniques. International Journal of Mechanical
Oncology, 9, 1132. Engineering, 6, 198-206.
https://doi.org/10.3389/fonc.2019.01132 https://kalaharijournals.com/resources/SP-
Chen, Z., Hu, S., Wang, S. A., Konopleva, M., Tang, Z., Vol.6_32.pdf
Xu, J., Li, Sh., Toruner, G., Thakral, B., Rahnemoon, A. R. (2022). Immunophenotyping
Medeiros, L. J., & Tang, G. (2020). Chronic investigation in acute and chronic leukemias as a
myeloid leukemia presenting in lymphoblastic gold standard test. Cancer Research and Cellular
crisis, a differential diagnosis with Philadelphia- Therapeutics, 6(1).
positive B-lymphoblastic leukemia. Leukemia & https://doi.org/10.31579/2640-1053/106
Lymphoma, 61(12), 2831-2838. Rajkumar, N. N., Raghavendra, H. V., Raghu, V. C., &
https://doi.org/10.1080/10428194.2020.1795160 Chinnagiriyappa, L. K. (2016). Flow
Esfahani, M. K., Morris, E. L., Dutcher, J. P., & immunophenotyping features of crisis phase of
Wiernik, P. H. (2006). Blastic phase of chronic chronic myeloid leukemia in childhood: Do we
myelogenous leukemia. Current Treatment really care? International Journal of Medical
Options in Oncology, 7(3), 189-199. Research and Review, 4(3), 463-469.
https://doi.org/10.1007/s11864-006-0012-y https://doi.org/10.17511/ijmrr.2016.i03.31
Hegde, V., Singh, S., Sinha, P., Dhar, L., Aggarwal, S., Shi, Y., Rand, A. J., Crow, J. H., Moore, J. O., &
Bhadoria, D. P., & Daga, M. K. (2020). Flow Lagoo, A. S. (2015). Blast phase in chronic
cytometry in chronic myelogenous leukemia blast myelogenous leukemia is skewed toward unusual
crisis. Iranian Journal of Blood and Cancer, blast types in patients treated with tyrosine kinase
12(3), 80-83. https://ijbc.ir/article-1-966-fa.pdf inhibitors: A comparative study of 67 cases.
Hehlmann, R., Saußele, S., Voskanyan, A., & American Journal of Clinical Pathology, 143(1),
Silver, R. T. (2016). Management of CML-blast 105-119.
crisis. Best Practice & Research Clinical https://doi.org/10.1309/AJCPWEX5YY4PHSCN
Haematology, 29(3), 295-307. Tembhare, P. R., Subramanian PG, P. G., Ghogale, S.,
https://doi.org/10.1016/j.beha.2016.10.005 Chatterjee, G., Patkar, N. V., Gupta, A.,
Hodkinson, K. E., Bouwer, N., & Vaughan, J. (2022). Shukla, R., Badrinath, Y., Deshpande, N.,
South African study of blast phase chronic Narula, G., Rodrigues, P., Girase, K.,
myeloid leukaemia: A poor prognostic outlook. Dhaliwal, D., Prasad, M., Shetty, D.,
African Journal of Laboratory Medicine, 11(1), Banavali, S., & Gujral, S. (2020). A high‐
1578. https://doi.org/10.4102/ajlm.v11i1.1578 sensitivity 10‐color flow cytometric minimal
Ivanov, S., Sharma, P., Jobanputra, Y., & Zhang, Y. residual disease assay in B‐lymphoblastic
(2020). Transformation of chronic myeloid leukemia/lymphoma can easily achieve the
leukemia to acute biphenotypic leukemia. Journal sensitivity of 2‐in‐106 and is superior to standard
of Medical Cases, 11(8), 239-242. minimal residual disease assay: A study of 622
https://doi.org/10.14740/jmc3511 patients. Cytometry Part B: Clinical Cytometry,
Khemka, R., Gupta, M., & Jena, N. K. (2019). CML with 98(1), 57-67. https://doi.org/10.1002/cyto.b.21831
megakaryocytic blast crisis: Report of 3 cases.

36